Women in their mid-follicular phase outcompete hormonal contraceptive users, an effect partially explained by relatively greater progesterone and cortisol reactivity to competition

Psychoneuroendocrinology. 2023 Nov:157:106367. doi: 10.1016/j.psyneuen.2023.106367. Epub 2023 Aug 15.

Abstract

Early evidence suggests that hormonal contraceptive (HC) use alters psychological functioning and competitive behavior. Yet, there is limited data on endocrine models for explaining how HC use affects these outcomes. In this pre-registered and open-data study, we test if HC users and naturally cycling (NC) females in their low (mid-follicular) and high (mid-luteal) progesterone phase differ in competitive persistence and whether progesterone and cortisol reactivity mediate of this effect. HC users (N = 73) in the active hormone-exposure phase and NC participants in the mid-follicular (N = 69) or mid-luteal (N = 72) phase completed two behavioral measures of competitive persistence, holding up a weight for time followed by attempting to solve an unsolvable anagram. Participants also completed measures of handgrip strength and self-reported competitiveness as well as gave saliva samples before and after the tasks for hormone assay. Results showed that NC-follicular group had greater competitive persistence in the weight-holding task compared to both NC-luteal (d = 0.38) and HC use (d = 0.43) groups independent of physical strength and self-reported competitiveness covariates. Although anagram task performance showed similar trends for group differences, analyses for this task were inconclusive. Baseline progesterone did not mediate the effect of cycle phase group on competitive persistence. HC users showed relatively blunted cortisol and progesterone reactivity, and this effect partially mediated the difference in competitive persistence between HC users and the NC-follicular group. In sum, results suggest that HC use could downregulate competitive behavior at least partly by dampening cortisol-progesterone reactivity. These findings offer a new endocrine model for understanding HC use and cycle phase effects on motivational and energetic outcomes required for optimal performance in competitive contexts.

Keywords: Competitive behavior; Cortisol; Hormonal contraceptives; Hormone reactivity; Menstrual cycle; Persistence; Progesterone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Contraceptive Agents
  • Estradiol / pharmacology
  • Female
  • Follicular Phase*
  • Hand Strength
  • Humans
  • Hydrocortisone / pharmacology
  • Menstrual Cycle / physiology
  • Progesterone* / pharmacology

Substances

  • Progesterone
  • Hydrocortisone
  • Contraceptive Agents
  • Estradiol